Company profile
Dianosic company profile
Dianosic is a biotechnology startup co-founded in 2017 by Marc Augustin, Philippe Bastide, and Prof. Christian Debry. The company develops complex intranasal formulations and advanced drug-delivery solutions for chronic respiratory diseases and central nervous system disorders. From its inception, Dianosic structured its development around the identification of unmet medical needs, relying on a high-level scientific advisory board and regular interactions with international Key Opinion Leaders to anchor its technological choices in concrete clinical challenges. The company initially focused on developing intranasal solid dosage forms for chronic rhinosinusitis and chronic allergic rhinitis, before expanding its platform toward applications in central nervous..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- https://dianosic.com/
- Contact email
- [email protected]
- Phone number
- +33144014580
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2017-07-01
Headquarters
- Headquarters
- Alsace, France, Strasbourg
- Postal code
- 67000
- Country code
- FR
- Continent
- Europe